Drugs / recFSH
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT01599494 | Mar 2014 → May 2015 | infertility disorder | Organon and Co | Withdrawn | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT07523022 | Sep 2024 → Sep 2026 overdue | male infertility | Szeged University | Enrolling by invitation | No outcome recorded |
| Phase 4 | NCT02430740 | Jan 2016 → Dec 2023 | infertility disorder | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00702845 Background | Dec 2006 → Jul 2007 | infertility disorder | Organon and Co | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | recFSH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07523022 ↗ |
| Modality | Protein / enzyme biologic | “daily recombinant follicle stimulating hormone (rFSH) from day 8 onwards” PMID 26991902 ↗ May 2016 |
| Route | Subcutaneous | “600 IU cartridge for SC injection via the recFSH Pen” NCT01599494 ↗ |